The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Olanzapine is an atypical antipsychotic drugs, it is suitable for schizophrenia and other severe positive symptoms (for example: delusions, hallucinations, thought disorder, hostility and suspicion) and / or negative symptoms (such as: apathy acute and maintenance treatment, emotional and social withdrawal, poverty of speech) psychosis. In this report, we research and analyze the olanzapine, which used for manufacturing the olanzapine tablets.
The global Olanzapine market was valued at US$ 193 million in 2023 and is anticipated to reach US$ 225.2 million by 2030, witnessing a CAGR of 2.2% during the forecast period 2024-2030.
Global Olanzapine key players include Lilly, Teva Pharmaceutical, Dr. Reddy's Laboratories, Apotex Inc, Hansoh Pharmaceutical, etc. Global top five manufacturers hold a share over 85%.
North America is the largest market, with a share over 70%, followed by Asia, which has a share over 25%.
In terms of product, Patent is the largest segment, with a share about 55%. And in terms of application, the largest application is Olanzapine Tablets, followed by Daily Commodities, etc.
This report aims to provide a comprehensive presentation of the global market for Olanzapine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Olanzapine.
Report Scope
The Olanzapine market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Olanzapine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Olanzapine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lilly
Teva Pharmaceutical
Dr. Reddy's Laboratories
Apotex Inc.
Mylan Pharmaceuticals
Par Pharmaceutical
Aurobindo Pharma
Torrent Pharmaceuticals
Jubilant Lifesciences
Sun Pharmaceutical
Sandoz
Hansoh Pharmaceutical
WATSON Pharmaceuticals(Changzhou)
Zhejiang Langhua Pharmaceuticals
Segment by Type
Patent
Generics
Segment by Application
Olanzapine Tablets
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Olanzapine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Olanzapine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Olanzapine is an atypical antipsychotic drugs, it is suitable for schizophrenia and other severe positive symptoms (for example: delusions, hallucinations, thought disorder, hostility and suspicion) and / or negative symptoms (such as: apathy acute and maintenance treatment, emotional and social withdrawal, poverty of speech) psychosis. In this report, we research and analyze the olanzapine, which used for manufacturing the olanzapine tablets.
The global Olanzapine market was valued at US$ 193 million in 2023 and is anticipated to reach US$ 225.2 million by 2030, witnessing a CAGR of 2.2% during the forecast period 2024-2030.
Global Olanzapine key players include Lilly, Teva Pharmaceutical, Dr. Reddy's Laboratories, Apotex Inc, Hansoh Pharmaceutical, etc. Global top five manufacturers hold a share over 85%.
North America is the largest market, with a share over 70%, followed by Asia, which has a share over 25%.
In terms of product, Patent is the largest segment, with a share about 55%. And in terms of application, the largest application is Olanzapine Tablets, followed by Daily Commodities, etc.
This report aims to provide a comprehensive presentation of the global market for Olanzapine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Olanzapine.
Report Scope
The Olanzapine market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Olanzapine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Olanzapine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lilly
Teva Pharmaceutical
Dr. Reddy's Laboratories
Apotex Inc.
Mylan Pharmaceuticals
Par Pharmaceutical
Aurobindo Pharma
Torrent Pharmaceuticals
Jubilant Lifesciences
Sun Pharmaceutical
Sandoz
Hansoh Pharmaceutical
WATSON Pharmaceuticals(Changzhou)
Zhejiang Langhua Pharmaceuticals
Segment by Type
Patent
Generics
Segment by Application
Olanzapine Tablets
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Olanzapine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Olanzapine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Olanzapine Market Overview
1.1 Product Overview and Scope of Olanzapine
1.2 Olanzapine Segment by Type
1.2.1 Global Olanzapine Market Value Comparison by Type (2024-2030)
1.2.2 Patent
1.2.3 Generics
1.3 Olanzapine Segment by Application
1.3.1 Global Olanzapine Market Value by Application: (2024-2030)
1.3.2 Olanzapine Tablets
1.3.3 Others
1.4 Global Olanzapine Market Size Estimates and Forecasts
1.4.1 Global Olanzapine Revenue 2019-2030
1.4.2 Global Olanzapine Sales 2019-2030
1.4.3 Global Olanzapine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Olanzapine Market Competition by Manufacturers
2.1 Global Olanzapine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Olanzapine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Olanzapine Average Price by Manufacturers (2019-2024)
2.4 Global Olanzapine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Olanzapine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Olanzapine, Product Type & Application
2.7 Olanzapine Market Competitive Situation and Trends
2.7.1 Olanzapine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Olanzapine Players Market Share by Revenue
2.7.3 Global Olanzapine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Olanzapine Retrospective Market Scenario by Region
3.1 Global Olanzapine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Olanzapine Global Olanzapine Sales by Region: 2019-2030
3.2.1 Global Olanzapine Sales by Region: 2019-2024
3.2.2 Global Olanzapine Sales by Region: 2025-2030
3.3 Global Olanzapine Global Olanzapine Revenue by Region: 2019-2030
3.3.1 Global Olanzapine Revenue by Region: 2019-2024
3.3.2 Global Olanzapine Revenue by Region: 2025-2030
3.4 North America Olanzapine Market Facts & Figures by Country
3.4.1 North America Olanzapine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Olanzapine Sales by Country (2019-2030)
3.4.3 North America Olanzapine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Olanzapine Market Facts & Figures by Country
3.5.1 Europe Olanzapine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Olanzapine Sales by Country (2019-2030)
3.5.3 Europe Olanzapine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Olanzapine Market Facts & Figures by Country
3.6.1 Asia Pacific Olanzapine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Olanzapine Sales by Country (2019-2030)
3.6.3 Asia Pacific Olanzapine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Olanzapine Market Facts & Figures by Country
3.7.1 Latin America Olanzapine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Olanzapine Sales by Country (2019-2030)
3.7.3 Latin America Olanzapine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Olanzapine Market Facts & Figures by Country
3.8.1 Middle East and Africa Olanzapine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Olanzapine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Olanzapine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Olanzapine Sales by Type (2019-2030)
4.1.1 Global Olanzapine Sales by Type (2019-2024)
4.1.2 Global Olanzapine Sales by Type (2025-2030)
4.1.3 Global Olanzapine Sales Market Share by Type (2019-2030)
4.2 Global Olanzapine Revenue by Type (2019-2030)
4.2.1 Global Olanzapine Revenue by Type (2019-2024)
4.2.2 Global Olanzapine Revenue by Type (2025-2030)
4.2.3 Global Olanzapine Revenue Market Share by Type (2019-2030)
4.3 Global Olanzapine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Olanzapine Sales by Application (2019-2030)
5.1.1 Global Olanzapine Sales by Application (2019-2024)
5.1.2 Global Olanzapine Sales by Application (2025-2030)
5.1.3 Global Olanzapine Sales Market Share by Application (2019-2030)
5.2 Global Olanzapine Revenue by Application (2019-2030)
5.2.1 Global Olanzapine Revenue by Application (2019-2024)
5.2.2 Global Olanzapine Revenue by Application (2025-2030)
5.2.3 Global Olanzapine Revenue Market Share by Application (2019-2030)
5.3 Global Olanzapine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Lilly
6.1.1 Lilly Corporation Information
6.1.2 Lilly Description and Business Overview
6.1.3 Lilly Olanzapine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Lilly Olanzapine Product Portfolio
6.1.5 Lilly Recent Developments/Updates
6.2 Teva Pharmaceutical
6.2.1 Teva Pharmaceutical Corporation Information
6.2.2 Teva Pharmaceutical Description and Business Overview
6.2.3 Teva Pharmaceutical Olanzapine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Teva Pharmaceutical Olanzapine Product Portfolio
6.2.5 Teva Pharmaceutical Recent Developments/Updates
6.3 Dr. Reddy's Laboratories
6.3.1 Dr. Reddy's Laboratories Corporation Information
6.3.2 Dr. Reddy's Laboratories Description and Business Overview
6.3.3 Dr. Reddy's Laboratories Olanzapine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Dr. Reddy's Laboratories Olanzapine Product Portfolio
6.3.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.4 Apotex Inc.
6.4.1 Apotex Inc. Corporation Information
6.4.2 Apotex Inc. Description and Business Overview
6.4.3 Apotex Inc. Olanzapine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Apotex Inc. Olanzapine Product Portfolio
6.4.5 Apotex Inc. Recent Developments/Updates
6.5 Mylan Pharmaceuticals
6.5.1 Mylan Pharmaceuticals Corporation Information
6.5.2 Mylan Pharmaceuticals Description and Business Overview
6.5.3 Mylan Pharmaceuticals Olanzapine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Mylan Pharmaceuticals Olanzapine Product Portfolio
6.5.5 Mylan Pharmaceuticals Recent Developments/Updates
6.6 Par Pharmaceutical
6.6.1 Par Pharmaceutical Corporation Information
6.6.2 Par Pharmaceutical Description and Business Overview
6.6.3 Par Pharmaceutical Olanzapine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Par Pharmaceutical Olanzapine Product Portfolio
6.6.5 Par Pharmaceutical Recent Developments/Updates
6.7 Aurobindo Pharma
6.6.1 Aurobindo Pharma Corporation Information
6.6.2 Aurobindo Pharma Description and Business Overview
6.6.3 Aurobindo Pharma Olanzapine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Aurobindo Pharma Olanzapine Product Portfolio
6.7.5 Aurobindo Pharma Recent Developments/Updates
6.8 Torrent Pharmaceuticals
6.8.1 Torrent Pharmaceuticals Corporation Information
6.8.2 Torrent Pharmaceuticals Description and Business Overview
6.8.3 Torrent Pharmaceuticals Olanzapine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Torrent Pharmaceuticals Olanzapine Product Portfolio
6.8.5 Torrent Pharmaceuticals Recent Developments/Updates
6.9 Jubilant Lifesciences
6.9.1 Jubilant Lifesciences Corporation Information
6.9.2 Jubilant Lifesciences Description and Business Overview
6.9.3 Jubilant Lifesciences Olanzapine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Jubilant Lifesciences Olanzapine Product Portfolio
6.9.5 Jubilant Lifesciences Recent Developments/Updates
6.10 Sun Pharmaceutical
6.10.1 Sun Pharmaceutical Corporation Information
6.10.2 Sun Pharmaceutical Description and Business Overview
6.10.3 Sun Pharmaceutical Olanzapine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Sun Pharmaceutical Olanzapine Product Portfolio
6.10.5 Sun Pharmaceutical Recent Developments/Updates
6.11 Sandoz
6.11.1 Sandoz Corporation Information
6.11.2 Sandoz Olanzapine Description and Business Overview
6.11.3 Sandoz Olanzapine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Sandoz Olanzapine Product Portfolio
6.11.5 Sandoz Recent Developments/Updates
6.12 Hansoh Pharmaceutical
6.12.1 Hansoh Pharmaceutical Corporation Information
6.12.2 Hansoh Pharmaceutical Olanzapine Description and Business Overview
6.12.3 Hansoh Pharmaceutical Olanzapine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Hansoh Pharmaceutical Olanzapine Product Portfolio
6.12.5 Hansoh Pharmaceutical Recent Developments/Updates
6.13 WATSON Pharmaceuticals(Changzhou)
6.13.1 WATSON Pharmaceuticals(Changzhou) Corporation Information
6.13.2 WATSON Pharmaceuticals(Changzhou) Olanzapine Description and Business Overview
6.13.3 WATSON Pharmaceuticals(Changzhou) Olanzapine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 WATSON Pharmaceuticals(Changzhou) Olanzapine Product Portfolio
6.13.5 WATSON Pharmaceuticals(Changzhou) Recent Developments/Updates
6.14 Zhejiang Langhua Pharmaceuticals
6.14.1 Zhejiang Langhua Pharmaceuticals Corporation Information
6.14.2 Zhejiang Langhua Pharmaceuticals Olanzapine Description and Business Overview
6.14.3 Zhejiang Langhua Pharmaceuticals Olanzapine Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Zhejiang Langhua Pharmaceuticals Olanzapine Product Portfolio
6.14.5 Zhejiang Langhua Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Olanzapine Industry Chain Analysis
7.2 Olanzapine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Olanzapine Production Mode & Process
7.4 Olanzapine Sales and Marketing
7.4.1 Olanzapine Sales Channels
7.4.2 Olanzapine Distributors
7.5 Olanzapine Customers
8 Olanzapine Market Dynamics
8.1 Olanzapine Industry Trends
8.2 Olanzapine Market Drivers
8.3 Olanzapine Market Challenges
8.4 Olanzapine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
